IRIS Accounts Production v22.2.0.402 03200946 director 1.1.21 31.12.21 31.12.21 0 0 false true false false true false Ordinary shares 1.00000 Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure032009462020-12-31032009462021-12-31032009462021-01-012021-12-31032009462019-12-31032009462020-01-012020-12-31032009462020-12-3103200946ns16:EnglandWales2021-01-012021-12-3103200946ns15:Euro2021-01-012021-12-3103200946ns11:Director12021-01-012021-12-3103200946ns11:PrivateLimitedCompanyLtd2021-01-012021-12-3103200946ns11:SmallEntities2021-01-012021-12-3103200946ns11:AuditExempt-NoAccountantsReport2021-01-012021-12-3103200946ns11:SmallCompaniesRegimeForDirectorsReport2021-01-012021-12-3103200946ns11:SmallCompaniesRegimeForAccounts2021-01-012021-12-3103200946ns11:FullAccounts2021-01-012021-12-3103200946ns11:OrdinaryShareClass12021-01-012021-12-3103200946ns11:OrdinaryShareClass22021-01-012021-12-3103200946ns11:RegisteredOffice2021-01-012021-12-3103200946ns6:CurrentFinancialInstruments2021-12-3103200946ns6:CurrentFinancialInstruments2020-12-3103200946ns6:ShareCapital2021-12-3103200946ns6:ShareCapital2020-12-3103200946ns6:RetainedEarningsAccumulatedLosses2021-12-3103200946ns6:RetainedEarningsAccumulatedLosses2020-12-3103200946ns6:WithinOneYearns6:CurrentFinancialInstruments2021-12-3103200946ns6:WithinOneYearns6:CurrentFinancialInstruments2020-12-3103200946ns11:OrdinaryShareClass12021-12-3103200946ns11:OrdinaryShareClass22021-12-3103200946ns6:RetainedEarningsAccumulatedLosses2020-12-3103200946ns6:RetainedEarningsAccumulatedLosses2021-01-012021-12-31
REGISTERED NUMBER: 03200946 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2021

for

Texpharma Limited

Texpharma Limited (Registered number: 03200946)






Contents of the Financial Statements
for the Year Ended 31 December 2021




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Texpharma Limited

Company Information
for the Year Ended 31 December 2021







DIRECTOR: Mrs P A Bissett





REGISTERED OFFICE: Birchin Court
20 Birchin Lane
London
EC3V 9DJ





REGISTERED NUMBER: 03200946 (England and Wales)





ACCOUNTANTS: Adbell International Limited
Birchin Court
20 Birchin Lane
London
EC3V 9DJ

Texpharma Limited (Registered number: 03200946)

Balance Sheet
31 December 2021

31.12.21 31.12.20
Notes €    €   
FIXED ASSETS
Investments 4 110 110

CURRENT ASSETS
Debtors 5 1,457,215 1,371,036

CREDITORS
Amounts falling due within one year 6 (22,896 ) (21,647 )
NET CURRENT ASSETS 1,434,319 1,349,389
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,434,429

1,349,499

CAPITAL AND RESERVES
Called up share capital 7 7 7
Retained earnings 8 1,434,422 1,349,492
SHAREHOLDERS' FUNDS 1,434,429 1,349,499

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 5 September 2022 and were signed by:





Mrs P A Bissett - Director


Texpharma Limited (Registered number: 03200946)

Notes to the Financial Statements
for the Year Ended 31 December 2021

1. STATUTORY INFORMATION

Texpharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared in accordance with Financial Reporting Standard 102 "The
Financial Reporting Standard applicable in the UK and Republic of Ireland" ("FRS 102") and the Companies Act 2006. The financial statements have been prepared under the historical cost convention except for the modification to fair value for the revaluation of the investment property.

The principal accounting policies adopted in the preparation of the financial statements are set out below. The accounting policies have been consistently applied within the financial statements.


The company's functional and presentation currency is € Euro.

Significant judgements and estimates
Preparation of the financial statements requires management to make significant judgements and estimates.

Turnover
Turnover represents the company's share of profit in the Texpharma partnership.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into Euro at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into Euro at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Texpharma Limited (Registered number: 03200946)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

2. ACCOUNTING POLICIES - continued

Financial instruments
Financial assets and financial liabilities are recognised when the company becomes a party to the contractual provisions of the instrument.

Financial assets and financial liabilities are recognised initially at fair value. Financial assets are reduced for provision, for impairment, if required.

Investments
Fixed asset investments are stated at cost less provision for diminution in value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2020 - NIL).

4. FIXED ASSET INVESTMENTS
Interest
in other
participating
interests
€   
COST
At 1 January 2021
and 31 December 2021 110
NET BOOK VALUE
At 31 December 2021 110
At 31 December 2020 110

The company has a 10% interest in a partnership, which trades outside the United Kingdom. The share of profit in the partnership for the year amounts to EUR 111,030 (2020 : EUR 105,006). The share of net assets in the partnership amounts to EUR 1,457,321 (2020 : EUR 1,371,142).

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.21 31.12.20
€    €   
Amounts owed by participating interests 1,457,211 1,371,032
Called up share capital not paid 4 4
1,457,215 1,371,036

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.21 31.12.20
€    €   
Tax 19,922 18,855
Accrued expenses 2,974 2,792
22,896 21,647

Texpharma Limited (Registered number: 03200946)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2021

7. CALLED UP SHARE CAPITAL



Allotted, issued and fully paid:
Number: Class: Nominal 31.12.21 31.12.20
value: €    €   
2 Ordinary shares £1 3 3
3 Ordinary shares £1 4 4
7 7

8. RESERVES
Retained
earnings
€   

At 1 January 2021 1,349,492
Profit for the year 84,930
At 31 December 2021 1,434,422

9. ULTIMATE CONTROLLING PARTY

The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company